Skip to main content

Latest ACR News

  • EurekAlert!
    GLP-1.injx
    A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide.
    Read Article
      No Result Found
      ×